PO.IM02.02 · 免疫学
手术诱导的长期固有免疫变化促进肿瘤进展
Surgery-induced long term innate immune changes facilitate tumor progression
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
引言:手术干预在癌症患者管理中至关重要,但由于促肿瘤性固有免疫,它可能增加肿瘤复发风险。我们假设手术应激可诱导骨髓细胞的持久重构,这些细胞在受到刺激时可分化为促肿瘤表型。
方法:野生型C57BL/6J小鼠接受手术应激,包括剖腹术、肝缺血再灌注和肝切除术。假手术包括麻醉但不进行进一步操作。在手术后1周或3周皮下接种MC38(小鼠结直肠癌细胞)。通过给予抗Ly6G单克隆抗体进行中性粒细胞清除。
结果:接受不同手术应激的野生型小鼠在术后1周或3周皮下接种肿瘤时显示肿瘤体积显著增加。然而,接受手术应激的中性粒细胞清除小鼠与野生型小鼠相比癌症生长无显著增加。这些发现与肿瘤相关中性粒细胞的转录组分析相关,后者表现出促进肿瘤生长的促炎因子产生增强。手术应激后的循环中性粒细胞在无癌情况下也显示类似的促炎标志物在术后持续上调。此外,接受手术预处理小鼠骨髓细胞的小鼠与假手术小鼠相比显示肿瘤体积增加。对骨髓祖细胞的分析特别显示,与假手术小鼠相比,手术后粒细胞-单核细胞祖细胞(GMP)增殖增强。此外,与假手术小鼠相比,手术预处理小鼠中GMP在响应癌症接种时的增殖增强。骨髓祖细胞的单细胞分析揭示术后持续的转录组变化,而转录因子富集揭示CCAAT/增强子结合蛋白(C/EBP)可能是这些持续变化的驱动因素。术后血浆分析揭示术后IL-1beta和HMGB1急性升高。用IL-1beta或HMGB1对骨髓祖细胞进行体外短期(3天)处理导致GMP增殖增强以及诱导的中性粒细胞中促肿瘤基因标志物持续上调。
结论:手术诱导的IL-1beta和HMGB1可诱导骨髓祖细胞的持续变化,从而在响应癌细胞时产生促肿瘤性中性粒细胞。IL-1beta和HMGB1可作为改善癌症患者手术切除后预后的靶点。
查看英文原文 English abstract
Introduction: Surgical intervention is crucial in managing cancer patients, yet it can increase tumor recurrence risk due to pro-tumorigenic innate immunity. We hypothesized that surgical stress can induce prolonged rewiring of bone marrow cells that can differentiate into a pro-tumorigenic phenotype upon stimulation.
Methods: Wild type C57BL/6J mice were subject to surgical stress including laparotomy, liver ischemia reperfusion and hepatectomy. Sham surgery includes anesthesia without further manipulation. MC38 (murine colorectal cancer cells) were subcutaneously inoculated 1- or 3-weeks post-surgery. Neutrophil depletion is done by anti-Ly6G monoclonal antibodies administration.
Results: Wild type mice subjected to different surgical stress showed significantly increased tumor volumes when tumor was inoculated subcutaneously 1- or 3-weeks post-surgery. However, neutrophil-depleted mice subjected to surgical stress showed no significant increase of cancer growth compared to wild type mice. These findings are correlated with transcriptomic analysis on tumor-associated neutrophils which exhibited enhanced production of pro-inflammatory factors that promote tumor growth. Circulating neutrophils after surgical stress also showed similar pro-inflammatory markers persistently upregulated after surgery in the absence of cancer. Furthermore, mice showed increased tumor volume when received bone marrow cells from surgery-preconditioned mice compared to sham mice. Analysis on bone marrow progenitor cells specifically showed enhanced proliferation of granulocyte-monocyte progenitors (GMPs) after surgery compared to sham mice. Additionally, proliferation of GMPs is enhanced in surgery-preconditioned mice compared to sham mice in response to cancer inoculation. Single-cell analysis of bone marrow progenitor cells revealed persistent transcriptomic changes post-surgery, while transcriptional factor enrichment revealed CCAAT/enhancer binding proteins (C/EBP) to be potential drivers of these persistent changes. Analysis of post-surgical plasma revealed acute increase of IL-1beta and HMGB1 post-surgery. In vitro short-term (3 days) treatment of bone marrow progenitor cells with IL-1beta or HMGB1 resulted in enhanced proliferation of GMPs and persistent upregulation of pro-tumorigenic gene markers in induced neutrophils.
Conclusions: Surgery-induced IL-1beta and HMGB1 can induce persistent changes in bone marrow progenitor cells that can produce pro-tumorigenic neutrophils in response to cancer cells. IL-1beta and HMGB1 can serve as targets to improve cancer patient prognosis after surgical resection.
利益披露 Disclosure
Z. He, None..
H. O. Yazdani, None..
T. Haykal, None..
R. Yang, None..
C. Tohme, None..
R. Kanamaru, None..
K. Wasson, None..
A. Gebran, None..
S. Liu, None..
D. A. Geller, None..
S. Tohme, None.